You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
McKinsey
Boehringer Ingelheim
McKesson

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

HOMATROPINE METHYLBROMIDE - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for homatropine methylbromide and what is the scope of patent protection?

Homatropine methylbromide is the generic ingredient in eight branded drugs marketed by Mission Pharma, Genus, Abhai Llc, Actavis Mid Atlantic, Hi Tech Pharma, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Paddock Llc, Torrent, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for homatropine methylbromide.

Summary for HOMATROPINE METHYLBROMIDE
US Patents:0
Tradenames:8
Applicants:15
NDAs:18
Drug Master File Entries: 5
Bulk Api Vendors: 62
Patent Applications: 414
DailyMed Link:HOMATROPINE METHYLBROMIDE at DailyMed
Synonyms for HOMATROPINE METHYLBROMIDE
(1R,3r,5S)-3-(2-hydroxy-2-phenylacetoxy)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-2-hydroxy-2-phenylacetate;bromide
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-oxidanyl-2-phenyl-ethanoate bromide
2-hydroxy-2-phenylacetic acid [(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester bromide
3-[2-hydroxy(phenyl)acetoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate
3alpha-Hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide mandelate
8-Azoniabicyclo(3.2.1)octane, 3-((2-hydroxy-2-phenylacetyl)oxy)-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, endo-
8-Azoniabicyclo[3.2.1]octane, 3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Methylhomatropinium bromide
8,8-dimethyl-8-azabicyclo[3.2.1]oct-3-yl 2-hydroxy-2-phenylacetate, bromide
80-49-9
A839929
AK163175
AKOS015896228
API0000400
Arkitropin
BCP13099
Benzeneacetic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
C16H21NO3.CH3Br
Camatropine
CCG-39581
CHEBI:50373
CHEMBL1200851
CS-5716
CTK5F7595
D02070
DB-056442
DB00725
DL-Homatropine methyl bromide
DTXSID4023127
EINECS 201-284-0
Equipin
Equipin (TN)
Esopin
H-2560
HMS1920D15
HMS2091J21
HMS3652C19
HMS500G13
Homapin
Homapin-10
Homapin-5
Homatromide
Homatropine (methylbromide)
Homatropine DL- methylbromide
Homatropine methobromide
Homatropine methyl bromide
Homatropine methylbromide (USP)
Homatropine methylbromide [INN:BAN]
Homatropine methylbromide [USP:INN:BAN]
homatropine-methylbromide
HOMATROPINEMETHYLBROMIDE
Homatropini methylbromidum
Homatropini methylbromidum [INN-Latin]
HOMATROPINIUM, 8-METHYL-, BROMIDE
HY-B1388
KS-00001722
LS-75887
Malcotran
MCULE-4330080118
Mesopin
Methylbromure d'homatropine
Methylbromure d'homatropine [INN-French]
Methylhomatropine bromide
Methylhomatropinum bromatum
Metilbromuro de homatropina
Metilbromuro de homatropina [INN-Spanish]
MFCD00050292
N-Methylhomatropinium Bromide
NCGC00094694-01
NCGC00094694-02
Novatrin
Novatrine
Novatropine
NSC 34399
NSC-757048
NSC34399
NSC757048
Omatropina metilbromuro
Omatropina metilbromuro [DCIT]
Pharmakon1600-01500333
Q2605497
S4024
SCHEMBL20659943
SCHEMBL77827
Sed-Tems
Sethyl
SPECTRUM1500333
SR-05000002082
SR-05000002082-1
ST24047389
ST50993907
SW219039-1
Tropinium methobromide mandelate
UNII-68JRS2HC1C component FUFVKLQESJNNAN-PGQIENJJSA-M

US Patents and Regulatory Information for HOMATROPINE METHYLBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040285-001 Jul 19, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Hi Tech Pharma HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040613-001 Feb 8, 2008 AA RX No Yes   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 088017-001 Jul 5, 1983 AA RX No No   Start Trial   Start Trial   Start Trial
Paddock Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 205731-001 Feb 15, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Genus HYCODAN homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 005213-001 Jul 26, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Novel Labs Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528-001 Apr 20, 2011 AA RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
McKinsey
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.